Nutriband Inc (NTRB)
$5.03 +0.12 (2.34%)Market Cap | 55.09M |
Revenue (ttm) | 2.09M |
Net Income (ttm) | -5.49M |
EPS (ttm) | N/A |
PE Ratio | 0.00 |
Forward PE | N/A |
Profit Margin | -262.68% |
Debt to Equity Ratio | 0.01 |
Volume | 6,658 |
Avg Vol | 73,724 |
Day's Range | N/A - N/A |
Shares Out | 11.11M |
Stochastic %K | 33% |
Beta | 1.19 |
Analysts | Strong Sell |
Price Target | $13.00 |
Latest News on NTRB

Apr 11, 2025, 7:00 AM EDT - 5 days ago
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Apr 4, 2025, 5:41 PM EDT - 11 days ago
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

Feb 21, 2025, 7:00 AM EST - 7 weeks ago
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Feb 13, 2025, 7:00 AM EST - 2 months ago
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Feb 7, 2025, 8:45 AM EST - 2 months ago
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Dec 27, 2024, 9:25 AM EST - 3 months ago
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Dec 4, 2024, 9:00 AM EST - 4 months ago
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Nov 27, 2024, 7:00 AM EST - 5 months ago
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Oct 31, 2024, 8:35 AM EDT - 5 months ago
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Oct 17, 2024, 7:00 AM EDT - 6 months ago
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Oct 2, 2024, 7:00 AM EDT - 7 months ago
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Sep 24, 2024, 7:00 AM EDT - 7 months ago
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 20, 2024, 6:50 AM EDT - 7 months ago
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Sep 4, 2024, 7:00 AM EDT - 8 months ago
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Jul 19, 2024, 7:00 AM EDT - 9 months ago
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Jul 15, 2024, 7:00 AM EDT - 9 months ago
Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Jun 20, 2024, 7:00 AM EDT - 10 months ago
Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

Jun 3, 2024, 7:00 AM EDT - 11 months ago
Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

May 16, 2024, 7:00 AM EDT - 11 months ago
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

May 10, 2024, 9:00 AM EDT - 1 year ago
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Apr 23, 2024, 7:00 AM EDT - 1 year ago
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

Mar 25, 2024, 7:00 AM EDT - 1 year ago
Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting


Jan 29, 2024, 7:00 AM EST - 1 year ago
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

Nov 28, 2023, 7:00 AM EST - 1 year ago
Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

Nov 8, 2023, 7:00 AM EST - 1 year ago
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

Oct 11, 2023, 7:42 AM EDT - 1 year ago
Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

Sep 20, 2023, 7:30 AM EDT - 1 year ago
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

Sep 12, 2023, 7:00 AM EDT - 1 year ago
Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023

Sep 11, 2023, 7:00 AM EDT - 1 year ago
Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 30, 2023, 8:00 AM EDT - 1 year ago
Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

Jul 27, 2023, 8:30 AM EDT - 1 year ago
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

Jul 14, 2023, 9:20 AM EDT - 1 year ago
Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

Jun 23, 2023, 7:00 AM EDT - 1 year ago
Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

Apr 19, 2023, 7:00 AM EDT - 2 years ago
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023

Mar 28, 2023, 8:00 AM EDT - 2 years ago
Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology

Mar 8, 2023, 8:00 AM EST - 2 years ago
Nutriband Inc Joins Webull Corporate Communications Service Platform

Mar 2, 2023, 8:00 AM EST - 2 years ago
Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee

Feb 15, 2023, 6:00 AM EST - 2 years ago
Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register

Jan 24, 2023, 6:00 AM EST - 2 years ago
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference

Dec 30, 2022, 6:30 AM EST - 2 years ago
Nutriband Inc. Will Be the First Company to Dual List on Upstream

Dec 29, 2022, 6:30 AM EST - 2 years ago